<- Back to digest

Spine - 2026-11-15 - Journal Article

Postoperative NSAID Prophylaxis is Associated With Decreased Rates of Heterotopic Ossification following Cervical Disc Arthroplasty.

Ehrlich AM, Owusu-Sarpong S, Asada T, Subramanian T, Pezzi A, Halayqeh S, Lui ATH, Durbas A, Zhao ER, Tuma OC, Araghi K, Harhash T, Kazarian GS, Kaidi AC, Dowdell JE, Morse KW, Farmer J, Huang RC, Albert TJ, Kim HJ, Qureshi SA, Iyer S

retrospective cohortLOE IIIn = 140Minimum 1–2 years radiographic follow-up.

Topics

arthroplastyspine
PMID: 41549724DOI: 10.1097/BRS.0000000000005627View on PubMed ->

Key Takeaway

Early postoperative NSAID use reduced HO formation following CDA (42.3% overall HO rate), with higher BMI independently increasing risk on multivariate analysis.

Summary Depth

Choose how much analysis to show on this article page.

Summary

This single-center retrospective cohort examined factors associated with HO formation in 140 CDA patients using McAfee classification grading. HO developed in 42.3% of patients; logistic regression identified higher BMI as an independent risk factor and early postoperative NSAID use (within 48 hours) as protective, both overall (P=0.033) and when used specifically for HO prophylaxis (P=0.01). Despite the high HO rate, PROMs, complications, and reoperation rates did not differ significantly between HO-positive and HO-negative groups.

Key Limitation

Retrospective, single-center design with non-standardized NSAID prescribing prevents determination of optimal agent, dose, or duration for HO prophylaxis.

Original Abstract

STUDY DESIGN

Retrospective cohort study.

OBJECTIVE

To identify factors associated with heterotopic ossification (HO) formation following cervical disc arthroplasty (CDA), including postoperative non-steroidal anti-inflammatory drug (NSAID) use.

SUMMARY OF BACKGROUND DATA

CDA preserves segmental motion in treating cervical degenerative disc disease but is susceptible to HO formation, which may compromise surgical outcomes. While NSAID prophylaxis is well-established in total hip arthroplasty to reduce HO risk, its role in CDA remains underexplored.

MATERIALS AND METHODS

A retrospective review was conducted at a single academic center using a maintained surgical registry. Patients undergoing CDA with at least 1 to 2 years of radiographic follow-up were included. Demographic variables, BMI, implant type, operative levels, and NSAID use (any reason vs . specifically for HO prophylaxis) within 48 hours postoperatively were collected. Radiographs were graded for HO severity using the McAfee classification. Two logistic regression analyses assessed associations between variables and HO formation. Patient-reported outcome measures (PROMs) and rates of complications and reoperations were compared between HO-positive and HO-negative groups.

RESULTS

Among 140 patients, 42.3% developed HO. HO presence was associated with higher age ( P =0.015), higher BMI ( P =0.004), and lower NSAID use both overall ( P =0.033) and specifically for HO prophylaxis ( P =0.01). Logistic regression confirmed that higher BMI was associated with increased HO risk, while postoperative NSAID use was associated with reduced risk. Clinical outcomes and PROMs improved significantly over time in both HO+ and HO- groups, with no significant differences in outcomes, complications, or reoperations.

CONCLUSION

Following multivariate analysis, higher BMI is associated with increased risk of HO following CDA, while early postoperative NSAID use is associated with a lower incidence. Clinical outcomes were similar between HO presence and absence groups. These findings support the potential role of NSAID prophylaxis in reducing HO development and guiding postoperative management following CDA.

LEVEL OF EVIDENCE

Level 3.